tamibarotene has been researched along with Thrombosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asakura, H; Nakao, S; Ohata, K; Shimadoi, S; Yamazaki, H | 1 |
Fujiu, K; Inoue, M; Katada, Y; Manabe, I; Nagai, R; Sasaki, M; Taguchi, T | 1 |
2 other study(ies) available for tamibarotene and Thrombosis
Article | Year |
---|---|
Tamibarotene-induced low-grade reversible intravascular coagulation in a patient with acute promyelocytic leukemia.
Topics: Aged; Antineoplastic Agents; Benzoates; Humans; Leukemia, Promyelocytic, Acute; Male; Tetrahydronaphthalenes; Thrombosis; Treatment Outcome | 2012 |
Poly-(L-lactic acid) and citric acid-crosslinked gelatin composite matrices as a drug-eluting stent coating material with endothelialization, antithrombogenic, and drug release properties.
Topics: Animals; Benzoates; Cell Proliferation; Citric Acid; Compomers; Cross-Linking Reagents; Delayed-Action Preparations; Drug-Eluting Stents; Endothelium, Vascular; Fibrinolytic Agents; Gelatin; Human Umbilical Vein Endothelial Cells; In Vitro Techniques; Lactic Acid; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Succinimides; Tetrahydronaphthalenes; Thrombosis | 2013 |